Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

(2018) Wolfgang Janni et al.   BREAST CANCER RESEARCH AND TREATMENT

Von ePregnancy zu Prelax: Von der Analyse der Anwenderinnen von Schwangerschaftsapplikationen hin zur Analyse der Compliance und des Benefits

(2016) S Wallwiener et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

(2016) Gabriel N. Hortobagyi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Palbociclib and Letrozole in Advanced Breast Cancer

(2016) Richard S. Finn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol

(2016) Bruno Kovic et al.   BMJ Open

Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients

(2015) Patricia J. Hollen et al.   BREAST CANCER RESEARCH AND TREATMENT

Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6- Reactivating Rb in cancer.

(2014) S. Kim et al.   MOLECULAR CANCER THERAPEUTICS

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

(2013) Howard A. Burris et al.   CANCER

Predictive factors for overall quality of life in patients with advanced cancer

(2013) Gemma Cramarossa et al.   SUPPORTIVE CARE IN CANCER

Management of cancer pain: ESMO Clinical Practice Guidelines

(2012) C. I. Ripamonti et al.   ANNALS OF ONCOLOGY

Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007

(2008) Ali Montazeri   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH